Sphingosine-1-phosphate (S1P) enhances glomerular endothelial cells activation mediated by anti-myeloperoxidase antibody-positive IgG
- PMID: 29168342
- PMCID: PMC5824416
- DOI: 10.1111/jcmm.13458
Sphingosine-1-phosphate (S1P) enhances glomerular endothelial cells activation mediated by anti-myeloperoxidase antibody-positive IgG
Abstract
Cumulating evidences suggested an important role of sphingosine-1-phosphate (S1P) and its receptors in regulating endothelial barrier integrity. Our previous study revealed that the circulating S1P levels and renal expression of S1PRs correlated with disease activity and renal damage in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). This study investigated the role of S1P and its receptors in myeloperoxidase (MPO)-ANCA-positive IgG-mediated glomerular endothelial cell (GEnC) activation. The effect of S1P on morphological alteration of GEnCs in the presence of MPO-ANCA-positive IgG was observed. Permeability assay was performed to determine endothelial monolayer activation in quantity. Both membrane-bound and soluble ICAM-1 and VCAM-1 levels were measured. Furthermore, antagonists and/or agonists of various S1PRs were employed to determine the role of different S1PRs. S1P enhanced MPO-ANCA-positive IgG-induced disruption of tight junction and disorganization of cytoskeleton in GEnCs. S1P induced further increase in monolayer permeability of GEnC monolayers in the presence of MPO-ANCA-positive IgG. S1P enhanced MPO-ANCA-positive IgG-induced membrane-bound and soluble ICAM-1/VCAM-1 up-regulation of GEnCs. Soluble ICAM-1 levels in the supernatants of GEnCs stimulated by S1P and MPO-ANCA-positive IgG increased upon pre-incubation of S1PR1 antagonist, while pre-incubation of GEnCs with the S1PR1 agonist down-regulated sICAM-1 level. Blocking S1PR2-4 reduced sICAM-1 levels in the supernatants of GEnCs stimulated by S1P and MPO-ANCA-positive IgG. Pre-incubation with S1PR5 agonist could increase sICAM-1 level in the supernatants of GEnC stimulated by S1P and MPO-ANCA-positive IgG. S1P can enhance MPO-ANCA-positive IgG-mediated GEnC activation through S1PR2-5.
Keywords: ANCA; sphingosine-1-phosphate; vasculitis.
© 2017 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.
Figures





Similar articles
-
Thrombin Contributes to Anti-myeloperoxidase Antibody Positive IgG-Mediated Glomerular Endothelial Cells Activation Through SphK1-S1P-S1PR3 Signaling.Front Immunol. 2019 Feb 15;10:237. doi: 10.3389/fimmu.2019.00237. eCollection 2019. Front Immunol. 2019. PMID: 30891029 Free PMC article.
-
High mobility group box-1 contributes to anti-myeloperoxidase antibody-induced glomerular endothelial cell injury through a moesin-dependent route.Arthritis Res Ther. 2017 Jun 6;19(1):125. doi: 10.1186/s13075-017-1339-4. Arthritis Res Ther. 2017. PMID: 28587670 Free PMC article.
-
Rho GTPases are involved in S1P-enhanced glomerular endothelial cells activation with anti-myeloperoxidase antibody positive IgG.J Cell Mol Med. 2018 Sep;22(9):4550-4554. doi: 10.1111/jcmm.13736. Epub 2018 Jul 11. J Cell Mol Med. 2018. PMID: 29993181 Free PMC article.
-
The role of myeloperoxidase and myeloperoxidase-antineutrophil cytoplasmic antibodies (MPO-ANCAs) in the pathogenesis of human MPO-ANCA-associated glomerulonephritis.Clin Exp Nephrol. 2013 Oct;17(5):634-637. doi: 10.1007/s10157-013-0787-7. Epub 2013 Mar 16. Clin Exp Nephrol. 2013. PMID: 23504409 Free PMC article. Review.
-
Myeloperoxidase-specific antineutrophil cytoplasmic antibody-associated vasculitis.Lancet Rheumatol. 2024 May;6(5):e300-e313. doi: 10.1016/S2665-9913(24)00025-0. Epub 2024 Apr 1. Lancet Rheumatol. 2024. PMID: 38574743 Review.
Cited by
-
Effects of sphingolipid metabolism disorders on endothelial cells.Lipids Health Dis. 2022 Oct 13;21(1):101. doi: 10.1186/s12944-022-01701-2. Lipids Health Dis. 2022. PMID: 36229882 Free PMC article. Review.
-
Novel Therapies for ANCA-associated Vasculitis: Apilimod Ameliorated Endothelial Cells Injury through TLR4/NF-κB Pathway and NLRP3 Inflammasome.Curr Pharm Des. 2024;30(29):2325-2344. doi: 10.2174/0113816128312530240607051608. Curr Pharm Des. 2024. PMID: 38910483
-
Signal Transduction and Gene Regulation in the Endothelium.Cold Spring Harb Perspect Med. 2023 Jan 3;13(1):a041153. doi: 10.1101/cshperspect.a041153. Cold Spring Harb Perspect Med. 2023. PMID: 35667710 Free PMC article. Review.
-
Plasma Exosomal S1PR5 and CARNS1 as Potential Non-invasive Screening Biomarkers of Coronary Heart Disease.Front Cardiovasc Med. 2022 Jun 28;9:845673. doi: 10.3389/fcvm.2022.845673. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35837598 Free PMC article.
-
Sphingolipid signaling in kidney diseases.Am J Physiol Renal Physiol. 2025 Mar 1;328(3):F431-F443. doi: 10.1152/ajprenal.00193.2024. Epub 2025 Feb 11. Am J Physiol Renal Physiol. 2025. PMID: 39933715 Free PMC article. Review.
References
-
- Jennette JC, Falk RJ, Bacon PA, et al Revised International Chapel Hill consensus conference Nomenclature of Vasculitis. Arthritis Rheum. 2013; 65: 1–11. - PubMed
-
- Segelmark M, Wieslander J. IgG subclasses of antineutrophil cytoplasm autoantibodies (ANCA). Nephrol Dial Transplant. 1993; 8: 696–702. - PubMed
-
- Chen M, Yu F, Zhang Y, et al Characteristics of Chinese patients with Wegener's granulomatosis with anti‐myeloperoxidase autoantibodies. Kidney Int. 2005; 68: 2225–9. - PubMed
-
- Li ZY, Chang DY, Zhao MH, et al Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody‐associated vasculitis: a study of 439 cases in a single Chinese center. Arthritis Rheumatol. 2014; 66: 1920–6. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous